Salinomycin overcomes acquired tamoxifen resistance through <i><scp>AIB</scp>1</i> and inhibits cancer cell invasion in endocrine resistant breast cancer

Suwisit Manmuan(Burapha University), Wannarasmi Ketchart(Chulalongkorn University), Nithidol Sakunrangsit(Chulalongkorn University)
Clinical and Experimental Pharmacology and Physiology
June 28, 2017
Cited by 10


Related Papers